Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $90.2100 (-1.58%) ($88.6900 - $91.9900) on Wed. Aug. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 20 | Latest Price | $90.2100(-1.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -9.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.305% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-9%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
1 - 5 Day Possible Target | $78.02(-13.51%) | Resistance Level | $104.83 | 5 Day Moving Average | $92.36(-2.33%) | 10 Day Moving Average | $96.73(-6.74%) | 20 Day Moving Average | $104.83(-13.95%) | To recent high | -25.6% | To recent low | 0.8% | Market Cap | $1.45b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |